高渗盐水对创伤性脑损伤脑血管反应性与代偿储备的影响:探索性分析
BACKGROUND: Intravenous hypertonic saline is utilized commonly in critical care for treatment of acute or refractory elevations of intracranial pressure (ICP) in traumatic brain injury (TBI) patients.…
要点
- HTS推注可有效降低TBI患者的ICP和AMP。
- 推注前PRx>+0.30者,HTS后脑血管反应性改善。
- 推注前PRx<0者,HTS后反应性呈受损趋势。
核心结论
- HTS推注能直接降低ICP和AMP,是治疗颅内高压的有效手段。
- 在自主调节功能完整的患者中,HTS可能损害脑血流动力学。
研究设计与样本
- 比较HTS推注前后不同时间段的脑生理参数,采用描述性统计和Mann-Whitney U检验。
- 使用潜在剖面分析(LPA)评估生理反应亚组。
主要发现
- HTS推注后ICP和AMP均下降。
- 推注前PRx>+0.30者,HTS后脑血管反应性改善。
- 推注前PRx<0者,HTS后脑血管反应性呈受损趋势。
- 脑代偿储备指标(AMP与ICP的相关性R)无显著变化。
- LPA未发现HTS生理反应的亚组。
关键数值与推荐
- 脑血管反应性以压力反应指数(PRx)衡量,推注前PRx>+0.30定义为反应性严重受损,PRx<0定义为反应性完整。
- 脑代偿储备以AMP(A)与ICP(P)的相关性(R)评估。
临床怎么用
- TBI患者使用HTS推注降低ICP时,应关注推注前脑血管反应性状态。
- 对自主调节功能完整的患者,HTS可能损害脑血流动力学,需谨慎使用。
局限性
- 脑血管反应性结果仅为初步发现,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intravenous hypertonic saline is utilized commonly in critical care for treatment of acute or refractory elevations of intracranial pressure (ICP) in traumatic brain injury (TBI) patients. Though there is a clear understanding of the general physiological effects of a hypertonic saline solution over long periods of time, smaller epoch effects of hypertonic saline (HTS) have not been thoroughly analyzed. The aim of this study was to perform a direct evaluation of the high-frequency response of HTS on the cerebrovascular physiological responses in TBI. METHODS: We retrospectively reviewed our prospectively maintained adult TBI database for those with archived high-frequency cerebral physiology and available HTS treatment information. We evaluated different epochs of physiology around HTS bolus dosing, comparing pre- with post-HTS. We assessed for changes in slow fluctuations in ICP, pulse amplitude of ICP (AMP), cerebral perfusion pressure (CPP), mean arterial pressure (MAP), cerebrovascular reactivity (as measured through pressure reactivity index (PRx)), and cerebral compensatory reserve (correlation (R) between AMP (A) and ICP (P)). Comparisons of mean measures and percentage time above clinically relevant thresholds for the physiological parameters were compared pre- and post-HTS using descriptive statistics and Mann-Whitney U testing. We assessed for subgroups of physiological responses using latent profile analysis (LPA). RESULTS: Fifteen patients underwent 69 distinct bolus infusions of hypertonic saline. Apart from the well-documented decrease in ICP, there was also a reduction in AMP. The analysis of cerebrovascular reactivity response to HTS solution had two main effects. For patients with grossly impaired cerebrovascular reactivity pre-HTS (PRx > + 0.30), HTS bolus led to improved reactivity. However, for those with intact cerebrovascular reactivity pre-HTS (PRx < 0), HTS bolus demonstrated a trend towards more impaired reactivity. This indicates that HTS has different impacts, dependent on pre-bolus cerebrovascular status. There was no significant change in metrics of cerebral compensatory reserve. LPA failed to demonstrate any subgroups of physiological responses to HTS administration. CONCLUSIONS: The direct decrease in ICP and AMP confirms that a bolus dose of a HTS solution is an effective therapeutic agent for intracranial hypertension. However, in patients with intact autoregulation, hypertonic saline may impair cerebral hemodynamics. These findings regarding cerebrovascular reactivity remain preliminary and require further investigation.
引用
- Froese L, Dian J, Batson C, et al. The impact of hypertonic saline on cerebrovascular reactivity and compensatory reserve in traumatic brain injury: an exploratory analysis. Acta Neurochir (Wien). 2020. PMID: 32959342. doi:10.1007/s00701-020-04579-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。